RxDoctor Payments Data

Eric Temple, DPM

Podiatrist · West Des Moines, IANPI 1831483676

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,338 of the $18,603 with a category attached, or 60.9%. 20 manufacturers reported payments, led by Acera Surgical, Inc. at 40.9% of the total. Reporting peaked in 2020 at $9,521 and has fallen 91.6% since, to $796 in 2025. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,603in general payments, 2019–2025

Across 104 payments — averaging $178.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$8K
  • Bone Support Inc.$4K
  • Ortho Solutions Inc$2K
  • Biogennix, LLC$1K
  • Johnson & Johnson$882
  • Medical Device Business Services, Inc.$728
  • plus $2K from 14 others
$4,000in research payments, 2019–2025

Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$4K

What the payments were for

  • Consulting fees$11,33861%
  • Speaking & faculty fees$1,0005%
  • Travel & lodging$1,1616%
  • Food & beverage$4,97527%
  • Education$1281%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,603 in reported general payments places this provider in the 95th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$126,576
Medicare patients
418
Services billed
2,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone89$653
Meloxicam315$527
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$387
Celecoxib18$284
Cephalexin11$165
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$27

Paid to pharmacies, not to this prescriber.

Other podiatrist in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →